The role of apoptosis in tumor progression and metastasis
- PMID: 14601637
- DOI: 10.2174/1566524033479483
The role of apoptosis in tumor progression and metastasis
Abstract
Metastasis, the process by which cancer spreads from a primary to a secondary site, is responsible for the majority of cancer related deaths. Yet despite the detrimental effects of metastasis, it is an extremely inefficient process by which very few of the cells that leave the primary tumor give rise to secondary tumors. Metastasis can be considered as a series of sequential steps that begins with a cell leaving a primary tumor, and concludes with the formation of a metastatic tumor in a distant site. During the process of metastasis cells are subjected to various apoptotic stimuli. Thus, in addition to genetic changes that promote unregulated proliferation, successful metastatic cells must have a decreased sensitivity to apoptotic stimuli. As many cancer cells exhibit aberrations in the level and function of key apoptotic regulators, exploiting these alterations to induce tumor cell apoptosis offers a promising therapeutic target. This review will examine the apoptotic regulators that are often aberrantly expressed in metastatic cells; the role that these regulators may play in metastasis; the steps of metastasis and their susceptibility to apoptosis; and finally, current and future cancer prognostics and treatment targets based on apoptotic regulators.
Similar articles
-
p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer.Breast Cancer Res. 2016 Jan 27;18(1):13. doi: 10.1186/s13058-016-0673-9. Breast Cancer Res. 2016. PMID: 26818199 Free PMC article.
-
Suppression of apoptosis by bcl-2 does not prevent p53-mediated control of experimental metastasis and anchorage dependence.Oncogene. 1997 Dec 18;15(25):3007-12. doi: 10.1038/sj.onc.1201723. Oncogene. 1997. PMID: 9444949
-
The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer.Oncotarget. 2016 Aug 2;7(31):49859-49877. doi: 10.18632/oncotarget.10489. Oncotarget. 2016. PMID: 27409664 Free PMC article.
-
Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site.J Urol. 2003 Mar;169(3):1122-33. doi: 10.1097/01.ju.0000051580.89109.4b. J Urol. 2003. PMID: 12576866 Review.
-
Metastasis suppressor genes: from gene identification to protein function and regulation.Cancer Biol Ther. 2005 Aug;4(8):805-12. doi: 10.4161/cbt.4.8.1865. Cancer Biol Ther. 2005. PMID: 16082183 Review.
Cited by
-
Identification of tyrosine-phosphorylated proteins associated with metastasis and functional analysis of FER in human hepatocellular carcinoma cells.BMC Cancer. 2009 Oct 16;9:366. doi: 10.1186/1471-2407-9-366. BMC Cancer. 2009. PMID: 19835603 Free PMC article.
-
Cytomorphology of circulating colorectal tumor cells:a small case series.J Oncol. 2010;2010:861341. doi: 10.1155/2010/861341. Epub 2010 Jan 6. J Oncol. 2010. PMID: 20111743 Free PMC article.
-
FAM129B/MINERVA, a novel adherens junction-associated protein, suppresses apoptosis in HeLa cells.J Biol Chem. 2011 Mar 25;286(12):10201-9. doi: 10.1074/jbc.M110.175273. Epub 2010 Dec 9. J Biol Chem. 2011. PMID: 21148485 Free PMC article.
-
Diet modulation is an effective complementary agent in preventing and treating breast cancer lung metastasis.Clin Exp Metastasis. 2014 Aug;31(6):625-38. doi: 10.1007/s10585-014-9654-5. Epub 2014 May 15. Clin Exp Metastasis. 2014. PMID: 24832758 Free PMC article.
-
Cytotoxic Compounds from Belamcanda chinensis (L.) DC Induced Apoptosis in Triple-Negative Breast Cancer Cells.Molecules. 2023 Jun 12;28(12):4715. doi: 10.3390/molecules28124715. Molecules. 2023. PMID: 37375271 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials